Turnstone Biologics Balance Sheet Health
Financial Health criteria checks 6/6
Turnstone Biologics has a total shareholder equity of $80.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $94.4M and $14.4M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$77.85m |
Equity | US$80.01m |
Total liabilities | US$14.38m |
Total assets | US$94.39m |
Financial Position Analysis
Short Term Liabilities: TSBX's short term assets ($85.0M) exceed its short term liabilities ($12.6M).
Long Term Liabilities: TSBX's short term assets ($85.0M) exceed its long term liabilities ($1.7M).
Debt to Equity History and Analysis
Debt Level: TSBX is debt free.
Reducing Debt: TSBX has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TSBX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: TSBX has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 9.5% each year.